Consolidated Statement Of Cash Flows

Astellas Pharma Inc. - Filing #7551605

Concept 2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
As at
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
As at
2023-03-31
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
33,129,000,000 JPY
JPY
33,129,000,000 JPY
33,129,000,000 JPY
JPY
JPY
24,812,000,000 JPY
24,812,000,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
24,812,000,000 JPY
JPY
JPY
JPY
Impairment losses (reversal of impairment losses)
10,535,000,000 JPY
22,035,000,000 JPY
Decrease (increase) in inventories
-16,756,000,000 JPY
4,113,000,000 JPY
Other
-18,989,000,000 JPY
19,667,000,000 JPY
Subtotal
19,036,000,000 JPY
81,519,000,000 JPY
Income taxes paid
-6,838,000,000 JPY
-32,688,000,000 JPY
Net cash provided by (used in) operating activities
12,198,000,000 JPY
48,832,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-10,062,000,000 JPY
-8,235,000,000 JPY
Purchase of intangible assets
-6,301,000,000 JPY
-10,024,000,000 JPY
Other
1,326,000,000 JPY
-1,341,000,000 JPY
Net cash provided by (used in) investing activities
-12,300,000,000 JPY
-19,144,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-10,731,000,000 JPY
-10,553,000,000 JPY
Other
-1,041,000,000 JPY
-682,000,000 JPY
Net cash provided by (used in) financing activities
165,041,000,000 JPY
-46,602,000,000 JPY
Cash and cash equivalents
561,487,000,000 JPY
376,840,000,000 JPY
313,013,000,000 JPY
315,986,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
19,708,000,000 JPY
13,941,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.